Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

University of California, USA
Title: Blood-based metabolomic biomarkers for human neurological disorders

Massimo S Fiandaca, MD, MBA, is a neuroscientist and Associate Professor in the Departments of Neurology and Neurological Surgery at the University of California Irvine (UCI). As Co-director of the Federoff Translational Laboratory and Biorepository (TLaB) at UCI, Dr. Fiandaca is currently focused on blood-based biomarkers related to neurological disorders. Through established local, national, and international collaborations, Dr. Fiandaca and colleagues hope to impact the development of relevant blood-based biomarkers for a variety of conditions affecting the nervous system. Dr. Fiandaca is a board certified neurological surgeon, who retired from surgical practice after 25 years, and returned to full-time academic research and teaching. His past research experiences have focused on direct brain delivery of therapeutics for neurodegenerative disorders and neurooncology, including cellular and tissue transplantation, viral-vector based therapeutic gene delivery, MRI-directed convection-enhanced delivery, and nanoliposomal therapeutics.


For many human maladies, especially neurodegenerative disorders (e.g., Alzheimer’s disease, AD, and Parkinson’s disease, PD) the ability to predict disease risk during asymptomatic stages is essential for earlier and more efficacious interventions. Blood-based biomarkers for AD (and PD), once defined and validated, may facilitate the participation of at-risk asymptomatic individuals in therapeutic clinical trials, and thereby increase the potential for successful prevention and/or disease modification. In conditions such as mild traumatic brain injury (mTBI), relevant blood bio-signatures could provide unbiased diagnostics that significantly improve clinical decision-making and improved treatments. Blood-based metabolomic biomarkers may offer such diagnostic and therapeutic potential in both AD and mTBI, as evidenced by our recent work. In this seminar, I plan to discuss our group’s approaches to blood-based metabolomic biomarker development and present results from our most recent metabolomic investigations related to AD and mTBI. We are encouraged by the potential provided by both untargeted and targeted metabolomic platforms in defining annotated species that are germane to the respective clinical conditions. We also provide caution to those exploring this area of research since there are many confounding factors that need close scrutiny in an effort to maximize clinical utility.

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by

Allied Academies Global Conference Directory

Mail us at

Drop us an email for Program enquiry
Sponsors / Exhibiting / Advertising
General Queries
More details about

Terms and Conditions

Cancellation, Postponement and Transfer of Registration

All cancellations or modifications of registration must be made in writing to

Cancellation Policy

If  Allied Academies cancels this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of cancellation.


If Allied Academies Ltd postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of postponement.

Transfer of registration

All fully paid registrations are transferable to other persons from the same organization, if registered person is unable to attend the event. Transfers must be made by the registered person in writing to Details must be included the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied Academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if it is intimated within 14 days of respective conference.
The transferred registrations will not be eligible for Refund.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied Academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied Academies, including the inability to obtain a visa.

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-
  • Before 60 days of the conference: Eligible for Full Refund less $150 service Fee
  • Within 60-30 days of Conference: Eligible for 40% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund

Accommodation Cancellation Policy:

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied Academies Ltd will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits.

Authorization Policy

Copyright © 2018-2019 Allied Academies, All Rights Reserved.